Healthcare Services

Genomic Selection Platform Market Expected to Record Steady Growth and Approach $4.96 Billion by 2030

April 1, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Will Be The Estimated Market Valuation Of The Genomic Selection Platform Market By The End Of 2030?

The genomic selection platform market has seen substantial growth in recent years. It is expected to expand from $2.27 billion in 2025 to $2.66 billion in 2026, achieving a compound annual growth rate (CAGR) of 17.1%. This historical growth can be attributed to the expansion of molecular breeding programs, increasing availability of genotyping technologies, the adoption of statistical genomics models, a rising demand for faster breeding cycles, and growing research investments in genetics.

The genomic selection platform market is set to experience substantial expansion over the next few years, with its valuation expected to reach $4.96 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 16.8%. This projected increase during the forecast period is driven by factors such as the growing adoption of genomic selection within agriculture, the rising application of predictive analytics in breeding programs, the broadening development of sustainable crop and livestock, the increasing integration of genomics with precision agriculture, and advancements in cloud-native genomic platforms. Significant trends for the forecast period include the increasing uptake of AI-driven genomic prediction models, the expanding use of high-throughput genotyping platforms, the growing integration of cloud-based breeding analytics, the wider implementation of predictive breeding decision support systems, and a heightened focus on the accuracy of trait-based selection.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=28237&type=smp

Which Market Drivers Are Supporting The Expansion Of The Genomic Selection Platform Market?

The expanding acceptance of personalized medicine is anticipated to drive the progress of the genomic selection platform market moving forward. Personalized medicine is a medical approach that customizes treatment and prevention strategies based on an individual’s distinct genetic makeup, lifestyle, and environment. The growing adoption of personalized medicine is mainly due to advances in genomics, which allow for the precise identification of genetic variations and customized treatments for individuals. Genomic selection platforms bolster personalized medicine by offering precise genomic insights, making them well-suited for tailoring treatments to individual patients. They minimize trial-and-error in therapy selection through predicting responses to interventions, thereby enhancing treatment effectiveness and improving patient outcomes. As an illustration, in February 2024, the Personalized Medicine Coalition (PMC), a US-based nonprofit organization, reported that the U.S. Food and Drug Administration (FDA) approved 26 new personalized medicines in 2023, a significant rise from the 12 approved in 2022. Consequently, the increasing adoption of personalized medicine is propelling the growth of the genomic selection platform market.

Genomic Selection Platform Market Driver: Increasing Crop Yields Fueling The Growth Of The Market Due To Enhancing Agricultural Productivity And Efficient Breeding

Which Segment Classifications Shape The Genomic Selection Platform Market?

The genomic selection platform market covered in this report is segmented –

1) By Component: Software, Hardware, Services

2) By Deployment Mode: On-Premises, Cloud-Based

3) By Application: Plant Breeding, Animal Breeding, Human Genomics, Other Applications

4) By End-User: Research Institutes, Biotechnology Companies, Agricultural Organizations, Other End-Users

Subsegments:

1) By Software: Genomic Data Management Software, Bioinformatics And Statistical Analysis Tools, DNA Or RNA Sequencing Data Processing Software, Genomic Prediction And Modeling Software, Cloud-Based Genomic Platforms, Workflow Automation And Integration Tools

2) By Hardware: Next-Generation Sequencing (NGS) Systems, Polymerase Chain Reaction (PCR) Instruments, Microarray Analyzers, High-Performance Computing (HPC) Systems, Data Storage Servers, Laboratory Automation And Robotics

3) By Services: Sequencing And Genotyping Services, Data Analysis And Interpretation Services, Cloud Hosting And Data Storage Services, Custom Bioinformatics Solutions, Training And Technical Support Services, Consulting And Implementation Services

How Are Trends Shaping The Direction Of The Genomic Selection Platform Market?

Leading companies in the genomic selection platform market are concentrating on developing innovative solutions, such as targeted sequencing platforms, to enhance trait prediction and accelerate breeding programs. Targeted sequencing platforms are genomic technologies and systems designed to sequence specific regions of the genome instead of the entire genome. For instance, in October 2024, Element Biosciences Inc., a US-based life sciences technology company, launched Trinity, a breakthrough targeted sequencing platform that streamlines exome capture by directly integrating traditionally complex steps into its AVITI System. The platform removes the necessity for specialized equipment, decreases manual work by up to five hours, and provides a one-hour hybridization option for same-day results, rendering it ideal for time-sensitive studies. Trinity extends its support to custom panels across diverse applications like oncology, respiratory diseases, and minimal residual disease (MRD). It delivers quicker, more cost-effective, and more accessible sequencing, signifying the first major advancement in exome capture.

Which Companies Are Expanding Their Footprint In The Genomic Selection Platform Market?

Major companies operating in the genomic selection platform market are F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., GE Healthcare Technologies Inc., Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., Beckman Coulter Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., MGI Tech Co. Ltd., Azenta Inc., 10x Genomics Inc., Oxford Nanopore Technologies plc, Ultima Genomics Inc., Element Biosciences Inc., DNAnexus Inc., Deep Genomics Inc., Epigene Labs Inc., Quotient Therapeutics Inc., Evogene Ltd., Nebula Genomics Inc., Verinomics Inc., InEdita Bio Inc., GenEmbryomics Inc., Enigma Genomics Inc.

Read the full genomic selection platform market report here:

https://www.thebusinessresearchcompany.com/report/genomic-selection-platform-global-market-report

How Is The Genomic Selection Platform Market Distributed Across Key Geographic Regions?

North America was the largest region in the genomic selection platform market in 2025. The regions covered in the genomic selection platform market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Genomic Selection Platform Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=28237&type=smp

Browse Through More Reports Similar to the Global Genomic Selection Platform Market 2026, By The Business Research Company

Genomics Global Market Report

https://www.thebusinessresearchcompany.com/report/genomics-global-market-report

Data Cleaning Tools Global Market Report

https://www.thebusinessresearchcompany.com/report/data-cleaning-tools-global-market-report

Next Generation Sequencing Market

https://www.thebusinessresearchcompany.com/report/next-generation-sequencing-market

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795